Haier Biomedical Unveils Advanced Biostorage Solutions at ISPE Singapore 2026

At the recent ISPE Singapore Conference & Exhibition 2026, Haier Biomedical showcased a suite of automated and digital solutions designed specifically for the pharmaceutical industry. This event, held on August 20-21 at Suntec Singapore, served as a pivotal platform for the introduction of cutting-edge technologies aimed at enhancing pharmaceutical research and production processes.

One of the standout features of the exhibition was the international debut of Haier Biomedical's automated ultra-low-temperature storage solution, designed to seamlessly handle the complex management of high-value biological samples at –80°C. In conjunction with this launch, the company also highlighted a pilot freeze dryer, emphasizing its commitment to facilitating the critical stages in the biopharmaceutical lifecycle—from research and development to production and quality control.

Understanding that efficiency and traceability are paramount in pharmaceutical workflows, Haier's automated storage solution integrates intelligent management systems that streamline sample handling. By automating storage processes, pharmaceutical firms can better maintain the integrity of their samples while improving workflow efficiency.

The pilot freeze dryer further complements this offering by enabling sophisticated freeze-drying capabilities that bridge laboratory experiments and industrial production. This dual approach not only fulfills diverse pharmaceutical requirements but also enhances operational capabilities across research, development, and manufacturing phases.

During a focused Power Hour session, Haier Biomedical provided insights into its Smart RFID ULT Storage Solution. This sophisticated system links physical samples with digital records, ensuring precise tracking throughout the storage lifecycle. By employing RFID technology, each sample is assigned a unique identity that simplifies data acquisition without the need for direct line-of-sight scanning. This innovative solution creates valuable structured records, detailing the inbound and outbound movements of each sample.

Moreover, this modular system accommodates various sample formats, including vials, bags, bottles, and cryovials, through customizable storage setups. The flexibility of the system ensures that it aligns with various operational needs in pharmaceutical environments, enhancing inventory management and overall supply chain visibility.

As the industry trends toward automation and data-driven methodologies, pharmaceutical companies now require interconnected workflows that maximize the efficacy of equipment and data across research, production, and quality assurance. Haier Biomedical’s wide-ranging portfolio, showcasing ULT freezers, refrigerated centrifuges, and advanced freeze-thaw systems, reflects this evolving need within the sector.

The company’s revenue growth statistics further highlight its success; in the first half of 2026, revenues associated with pharmaceutical clients soared by 23% compared to the previous year. Additionally, revenue from laboratory solutions experienced a 19% uptick, while contributions from AI-focused projects rose to 18%, marking a 3% increase from 2025.

Haier Biomedical’s strategy revolves around expanding its influence beyond standalone equipment, moving towards comprehensive multi-product solutions and consistently delivering support services. By further localizing its products to meet regional regulations and customer requirements, Haier aims to aid pharmaceutical entities in developing smarter, more interconnected, and scalable research and production frameworks.

This showcase at ISPE Singapore is a testament to Haier Biomedical’s dedication to pioneering advancements in the biopharmaceutical landscape, positioning itself as a leader in innovative solutions designed to meet the industry's dynamic demands.